Skip to main content
. 2016 Oct 9;8(3):5474–5486. doi: 10.18632/oncotarget.12547

Figure 5. Subgroup analyses in hepatocellular carcinoma patients according to the tumor size.

Figure 5

For tumor size ≤ 5 cm (n = 176), A., Comparison of overall survival rate: high-MVI vs non-MVI (P < 0.001); high-MVI vs low-MVI (P = 0.045); low-MVI vs non-MVI (P = 0.277). B., Comparison of recurrence-free survival rate: high-MVI vs non-MVI (P = 0.001); high-MVI vs low-MVI (P = 0.035); low-MVI vs non-MVI (P = 0.678). For tumor size > 5 cm (n = 119), C., Comparison of overall survival rate: high-MVI vs non-MVI (P < 0.001); high-MVI vs low-MVI (P < 0.001); low-MVI vs non-MVI (P = 0.404). D., Comparison of recurrence-free survival rate: high-MVI vs non-MVI (P < 0.001); high-MVI vs low-MVI (P = 0.006); low-MVI vs non-MVI (P = 0.341).